Daily Stock Analysis, AGS, AGILE THERAPEUTICS INC, priceseries

AGILE THERAPEUTICS INC. Daily Stock Analysis
Stock Information
Open
12.08
Close
12.10
High
12.32
Low
11.86
Previous Close
11.98
Daily Price Gain
0.12
YTD High
27.85
YTD High Date
Mar 6, 2019
YTD Low
6.05
YTD Low Date
Aug 8, 2019
YTD Price Change
-11.44
YTD Gain
-48.60%
52 Week High
27.85
52 Week High Date
Mar 6, 2019
52 Week Low
6.05
52 Week Low Date
Aug 8, 2019
52 Week Price Change
-8.51
52 Week Gain
-41.29%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 28. 2018
25.33
Jul 17. 2018
28.06
12 Trading Days
10.79%
Link
LONG
Jan 4. 2019
22.74
Jan 29. 2019
24.87
16 Trading Days
9.35%
Link
LONG
Mar 5. 2019
24.25
Mar 18. 2019
25.98
9 Trading Days
7.13%
Link
Company Information
Stock Symbol
AGS
Exchange
NASDAQ
Company URL
http://www.agiletherapeutics.com
Company Phone
609-683-1880
CEO
Al Altomari
Headquarters
New Jersey
Business Address
101 POOR FARM ROAD, PRINCETON, NJ 08540-1715
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0001261249
About

Agile Therapeutics, Inc. engages in the development and commercialization of new prescription contraceptive products. Its product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company was founded on December 22, 1997 and is headquartered in Princeton, NJ.

Description

Agile Therapeutics, Inc., a forward-thinking women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly contraceptive patch, which completed Phase III clinical trials. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.